China National Medicines Corp Ltd Asset Resilience Ratio
China National Medicines Corp Ltd asset resilience ratio. China National Medicines Corp Ltd (600511) has an Asset Resilience Ratio of 0.04% as of December 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 600511 current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of China National Medicines Corp Ltd (2004–2021)
Asset resilience ratio of China National Medicines Corp Ltd from 2004 to 2021. This chart shows how China National Medicines Corp Ltd's Asset Resilience Ratio has changed over time. See cash generation quality of China National Medicines Corp Ltd to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down China National Medicines Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 600511 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥11.40 Million | 0.04% |
| Total Liquid Assets | CN¥11.40 Million | 0.04% |
Asset Resilience Insights
- Limited Liquidity: China National Medicines Corp Ltd maintains only 0.04% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
China National Medicines Corp Ltd Industry Peers by Asset Resilience Ratio
Compare China National Medicines Corp Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.04% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
TELES Informationstechnologien AG
XETRA:TLIK |
Medical Distribution | 0.37% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 3.91% |
China National Medicines Corp Ltd Asset Resilience Ratio by Year (2004–2021)
China National Medicines Corp Ltd asset resilience ratio by year from 2004 to 2021. The table below shows the annual Asset Resilience Ratio data for China National Medicines Corp Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 0.04% | CN¥11.40 Million ≈ $1.67 Million |
CN¥27.48 Billion ≈ $4.02 Billion |
+0.03pp |
| 2004-12-31 | 0.02% | CN¥183.50K ≈ $26.85K |
CN¥1.19 Billion ≈ $174.55 Million |
-- |
About China National Medicines Corp Ltd
China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental academic services, warehousing, logistics and import and export agency services. It also serves hospitals, re… Read more